Dar Al-Shifa Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030

Updated on 03/29/2024

Stock Rating
0
Price Target
3.71
Consensus
-
Upside
12.42%
Analysts
0
Stock Rating
0
Upside
12.42%
Analysts
0
Price Target
3.71

Dar Al-Shifa Pharmaceuticals Stock Forecast and Price Target

Based on the current earnings figures, this year's price targets for Dar Al-Shifa Pharmaceuticals were recently set by distinguished experts, with an average mark of 3.71. If it reached this goal, it would represent a potential upside of approximately 12.42% from the previous closing price in October, 2021. The high end is 4.16, and the low is 3.30. If you want to invest in PHARMACARE stock, you might also want to take a look at how its competitors are doing.

3.71

12.42% Upside

-

Dar Al-Shifa Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030

In the last year, Price for Dar Al-Shifa Pharmaceuticals has grown by 100.00%, going from 0.00 to 0.00. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach 3.22 – an increase of 100.00%. Over the next eight years, experts anticipate that Fair Value growth for Dar Al-Shifa Pharmaceuticals will be 100.00%.

2023 Fair Value Forecast
3.22
2024 Fair Value Forecast
3.53
2025 Fair Value Forecast
3.86
2026 Fair Value Forecast
4.23
2027 Fair Value Forecast
4.62
2028 Fair Value Forecast
5.05
2029 Fair Value Forecast
5.53
2030 Fair Value Forecast
6.05
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LLY Stock Forecast Eli Lilly and Outperform 16
$734.37 Buy/Sell $636.99 10.71%
JNJ Stock Forecast Johnson & Johnson Outperform 9
$161.23 Buy/Sell $174.55 5.44%
MRK Stock Forecast Merck Outperform 2
$122.77 Buy/Sell $130.51 9.96%
AZN Stock Forecast AstraZeneca PLC Outperform 17
£104.50 Buy/Sell £165.99 53.79%
PFE Stock Forecast Pfizer Outperform 2
$28.37 Buy/Sell $32.87 10.82%

Dar Al-Shifa Pharmaceuticals Revenue Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BMY Stock Forecast Bristol-Myers Squibb Hold 2
$54.36 Buy/Sell $58.15 1.18%
VRTX Stock Forecast Vertex Pharmaceuticals Inc Outperform 12
$414.47 Buy/Sell $457.59 8.57%
REGN Stock Forecast Regeneron Pharmaceuticals Outperform 2
$964.44 Buy/Sell $961.26 8.87%

Dar Al-Shifa Pharmaceuticals Dividend per Share Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
GSK Stock Forecast GSK Outperform 12
£16.75 Buy/Sell £17.30 11.04%
ZTS Stock Forecast Zoetis Outperform 18
$183.49 Buy/Sell $220.47 20.72%
MRK Stock Forecast Merck KGaA Outperform 18
156.75€ Buy/Sell 190.06€ 9.73%

Dar Al-Shifa Pharmaceuticals Free Cash Flow Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
AGN Stock Forecast Allergan - 0
$47.83 Buy/Sell $193.25 -100.00%
BAX Stock Forecast Baxter International Inc Outperform 17
$43.48 Buy/Sell $44.86 3.50%
ALNY Stock Forecast Alnylam Pharmaceuticals Inc Outperform 7
$149.10 Buy/Sell $245.24 44.20%

Dar Al-Shifa Pharmaceuticals EBITDA Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
VTRS Stock Forecast Viatris Inc Hold 8
$11.97 Buy/Sell $11.73 0.25%
UTHR Stock Forecast United Therapeutics Outperform 12
$249.51 Buy/Sell $284.08 19.63%
CTLT Stock Forecast Catalent Hold 15
$56.81 Buy/Sell $49.29 11.78%

Dar Al-Shifa Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
IPN Stock Forecast Ipsen Outperform 17
106.40€ Buy/Sell 127.95€ 9.96%
CYTK Stock Forecast Cytokinetics Outperform 10
$64.39 Buy/Sell $87.92 45.99%
IONS Stock Forecast Ionis Pharmaceuticals Outperform 9
$43.26 Buy/Sell $55.60 41.01%

Dar Al-Shifa Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last year, EPS for Dar Al-Shifa Pharmaceuticals has grown by 100.00%, going from 0.00 to 0.00. In the coming year, analysts are expecting an increase in EPS, predicting it will reach 0.00 – an increase of 100.00%. Over the next eight years, experts anticipate that EPS growth for Dar Al-Shifa Pharmaceuticals will be 100.00%.

2023 EPS Forecast
0.00
2024 EPS Forecast
0.00
2025 EPS Forecast
0.00
2026 EPS Forecast
0.00
2027 EPS Forecast
0.00
2028 EPS Forecast
0.00
2029 EPS Forecast
0.00
2030 EPS Forecast
0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
HIK Stock Forecast Hikma Pharmaceuticals PLC Outperform 18
£19.10 Buy/Sell £28.11 55.34%
DPH Stock Forecast Dechra Pharmaceuticals PLC - 18
£38.66 Buy/Sell £39.86 -45.73%
BCPC Stock Forecast Balchem Outperform 18
$156.04 Buy/Sell $145.00 4.46%